The board meeting for Teva- Pharmaceutical Industries Ltd. - ADR is scheduled for today, for the purpose of Morgan Stanley 23rd Annual Global Healthcare ConferenceSee details
Teva- Pharmaceutical Industries Ltd. - ADR has a share price target of US$ 24, revenue growth forecast of 2.1%, and profit growth estimate of 160.3% for FY25, based on top 11 analyst calls.